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ABSTRACT
Clinical DNA is often available in limited quantities
requiring whole-genome amplification for subse-
quent genome-wide assessment of copy-number
variation (CNV) by array-CGH. In pre-implantation
diagnosis and analysis of micrometastases, even
merely single cells are available for analysis.
However, procedures allowing high-resolution anal-
yses of CNVs from single cells well below resolution
limits of conventional cytogenetics are lacking.
Here, we applied amplification products of single
cells and of cell pools (5 or 10 cells) from patients
with developmental delay, cancer cell lines and
polar bodies to various oligo tiling array platforms
with a median probe spacing as high as 65bp.
Our high-resolution analyses reveal that the low
amounts of template DNA do not result in a comple-
tely unbiased whole genome amplification but that
stochastic amplification artifacts, which become
more obvious on array platforms with tiling path
resolution, cause significant noise. We implemented
a new evaluation algorithm specifically for the iden-
tification of small gains and losses in such very
noisy ratio profiles. Our data suggest that when
assessed with sufficiently sensitive methods high-
resolution oligo-arrays allow a reliable identification
of CNVs as small as 500kb in cell pools (5 or
10 cells), and of 2.6–3.0 Mb in single cells.
INTRODUCTION
Many clinical applications, such as pre-implantation and
non-invasive prenatal diagnosis, would beneﬁt from the
ability to characterize the entire genome of individual
single cells by high resolution. Furthermore, in speciﬁc
cancer research applications, such as the investigation of
disseminated tumor cells (micrometastases) in bone
marrow or circulating tumor cells in blood, often only
single cells or very small cell numbers are available for
analyses. The same applies to precancerous lesions, such
as cells with dysplasia or early adenomas. In addition,
due to the discovery that the genome of all humans has
copy-number variations (CNVs) (1–3) and that these may
contribute to phenotype variability and disease suscepti-
bility (4), screening of whole genomes for CNVs represents
one of the most fascinating areas in human genetics at
present. More recently, evidence was reported that
CNVs may arise in somatic cells resulting in somatic
CNV mosaicism in diﬀerentiated human tissues (5,6).
The prospect that the presence of some CNVs may be
limited to conﬁned somatic areas and their potential
impact on physiological processes further fuels the need
for reliable CNV screening approaches in small cell
amounts.
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scanning of the whole genome for CNVs. However,
CGH is usually performed with DNA extracted from
thousands of cells and thus measures the average copy
number of a large population of cells. Accordingly,
CGH is sensitive to CNV heterogeneity within the cell
population. Without preceding special, unbiased whole
genome ampliﬁcation, CGH is not amenable to single
cell or few cell analyses.
Recently, ﬁrst results were published describing the
hybridization of single cell ampliﬁcation products to var-
ious array platforms. Initial studies reported resolution
limits of entire chromosomes (7) or of 34 Mb at best (8)
and thus failed to demonstrate a signiﬁcant improvement
compared with conventional methodologies. By using the
GenomePlex library technology for DNA ampliﬁcation
(GenomePlex Single Cell Whole Genome Ampliﬁcation
Kit, Sigma-Aldrich), we reported that copy number
changes as small as 8.3 Mb in single cells can be detected
reliably (9). Another group employed a 3.000 BAC array
and achieved the detection of about 60% of gains, losses
and interspersed normal regions ‘smaller than 20 Mb’ (10).
Therefore, to the best of our knowledge, even the
most advanced published single cell array-CGH technol-
ogies have resolution limits which represent only a slight
improvement as compared to conventional CGH on
metaphase spreads.
These earlier studies do not oﬀer a detailed map of
how robust a genome with CNVs is represented when
whole genome ampliﬁcation products are applied to
oligo tiling arrays. To this end, we speciﬁcally selected
clinical samples from some individuals in which previous
analyses had revealed deﬁned deletions on chromosome
22. We performed analyses on oligo tiling array platforms,
which possess the highest density of oligonucleotides at
present, i.e. NimbleGen’s Chromosome 22 Tiling array
(HG18 CHR22 FT) covering 385.210 oligos resulting in
a median probe spacing of 65bp and to a custom made
chromosome 22 array (Agilent) with 241.700 oligo probes
and a median probe spacing of 104bp. In addition, we
employed the NimbleGen Whole Genome Tiling Array
(HG18 WG Tiling 2.1M CGH v2.0D) consisting of
2.1-million oligo probes, resulting in a median probe spac-
ing of 1169bp. During the evaluation of these cells, we
noted that standard array CGH-evaluation programs are
not suited for the evaluation of single cell ampliﬁcation
products and we therefore developed a new algorithm.
In order to test the robustness of this algorithm and to
start to address speciﬁc biological questions, we analyzed
single cells from two cancer cell lines and polar bodies on a
244K whole genome array (Agilent).
As reported previously multiple displacement ampliﬁca-
tion with 29 polymerase results in diﬀerent ampliﬁcation
of regions in relation to the GC content (11). The same
applies to a linker adaptor whole genome ampliﬁcation
approach (12), because when these ampliﬁcation products
were hybridized to a BAC array GC rich regions on chro-
mosome 19 had to be excluded from analysis (10). As
we did not observe any nucleotide related ampliﬁcation
bias when applying the GenomePlex library technology
to a tiling BAC array (9), we applied this ampliﬁcation
method to all experiments described here.
MATERIALS AND METHODS
Samples from clinical cases, cancer cell lines and
polar bodies
We used cells from two probands (P1 and P2) with mental
retardation and dysmorphic features in whom previous
analyses performed on the whole genome 44K Agilent
array had shown deletions on chromosome 22 with sizes
of 2.8 Mb (P1) and 3 Mb and 1.2 Mb (both P2), respec-
tively. Furthermore, we prepared new cells from the stable
female renal cell carcinoma cell line 769P, because we are
very familiar with this cell line from previous analyses
(9) and the colorectal cancer cell line HT29, which is
known to be chromosomally instable (13). For polar
body analyses oocyte collection and processing were
done according to standard protocols.
Isolation of single cells and whole genome amplification
Cultured cells were centrifuged at 700g for 10min,
re-suspended in 1PBS and transferred onto a polyethy-
lene-naphthalate (PEN) membrane covered microscope
slide (Zeiss, Austria) by cyto-centrifugation at 120g for
3min. After removing the supernatant, slides were air
dried at room temperature overnight. Isolation of single
cells and cell pools was carried out using a laser micro-
dissection and pressure catapulting system (LMPC;
P.A.L.M., Zeiss, Austria). Single cells and cells pools
were randomly selected and directly catapulted into
the cap of a 200ml Eppendorf tube containing 10ml diges-
tion mix.
We performed whole genome ampliﬁcation of the single
cells and cell pools according to our recently published
protocol (9,14). In brief, we employed the GenomePlex
Single Cell Whole Genome Ampliﬁcation Kit (#WGA4;
Sigma-Aldrich, Germany) according to the manufac-
turer’s instructions with some modiﬁcations. In a ﬁnal
volume of 10ml, the specimens were centrifuged at
20.800g for 10min at 48C. After cell lysis and Proteinase
K digest, the DNA was fragmented and libraries were
prepared. Ampliﬁcation was performed by adding 7.5ml
of 10 Ampliﬁcation Master Mix, 51ml of nuclease-free
water and 1.5ml Titanium Taq DNA Polymerase
(#639208; Takara Bio Europe/Clontech, France).
Samples were ampliﬁed using an initial denaturation of
958C for 3min followed by 25 cycles, each consisting of
a denaturation step at 948C for 30s and an annealing/
extension step at 658C for 5min. After puriﬁcation using
the GenElute PCR Clean-up Kit (#NA1020; Sigma-
Aldrich, UK), DNA concentration was determined
by a Nanodrop spectrophotometer. Ampliﬁed DNA was
stored at 208C.
The quality of the ampliﬁcation was evaluated using
a multiplex PCR approach (15) and samples with
four bands on an agarose gel were selected for further
array-CGH analysis.
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We carried out array-CGH using various oligonucleotide
microarray platforms as outlined in the text. For the ana-
lysis of ampliﬁed DNA samples, reference DNA ampliﬁed
with the same protocol as described above was used.
Agilent platform. Samples were labeled with the Bioprime
Array CGH Genomic Labeling System (#18095-12,
Invitrogen, Carlsberg, CA) according to the manufac-
turer’s instructions. Brieﬂy, 500ng test DNA and refer-
ence DNA were diﬀerentially labeled with dCTP-Cy5 or
dCTP-Cy3 (#PA53021 and #PA55021, GE Healthcare,
Piscataway, NJ). Slides were scanned using a microarray
scanner (#G2505B; Agilent Technologies, Santa
Clara, CA).
NimbleGen platform. Hybridizations on the 2.1M whole
genome array (HG18 WG Tiling 2.1M CGH v2.0D) and
the chromosome 22 speciﬁc 385K array (HG18 CHR22
FT, both Roche NimbleGen Systems, Reykjavik, Iceland)
were performed at service from Roche NimbleGen.
Array-CGH evaluation platform
Data normalization and calculation of ratio values were
conducted employing NimbleGen’s NimbleScan software
package and the Feature Extraction software 9.1 from
Agilent Technologies, respectively. The algorithm devel-
oped for this study focuses on detecting which ratio
values diﬀer signiﬁcantly [two times standard deviation
(SD)] from the ratio proﬁle’s mean and should therefore
be considered as over- or underrepresented. The concept
of the algorithm includes the employment of running
means with diﬀerent window sizes and analyses at progres-
sively greater levels of smoothing and then combining
these analyses.
The algorithm is implemented in ‘R’ (version 2.7.0) (16)
and addresses three speciﬁc issues (i.e. location of win-
dows, window size and threshold selection), which have
a signiﬁcant impact on the identiﬁcation of very small
CNVs in noisy CGH-proﬁles.
Positioning of windows. Consecutive data points are com-
bined and their mean ratio values are presented in graphs
of array-CGH results. The algorithm iterates through the
proﬁle by changing window positions, employing a sliding
window approach.
The positioning of such windows may have an impact
on the ability to detect small CNVs: the scheme in
Supplementary Figure 1a illustrates a heterozygous dele-
tion (black), the windows (red) used for the calculation of
mean ratio values, and their calculated ratio proﬁles
(blue). In the example on the left side, one window (light
red) is located directly inside the deletion, thus the mean
ratio value characterizing this region will reﬂect the actual
DNA loss. In addition, the size of the deletion is shown
correctly in the ratio proﬁle. On the right side of
Supplementary Figure 1a, the windows are positioned in
such a way that two windows cover deleted and undeleted
regions by half. As a result, these two windows are
assigned mean ratio values generated in equal parts from
balanced and lost regions. Therefore, the decrease of the
ratio value will be lower and the region displayed in the
proﬁle (i.e. the size of the two windows) will be larger than
the actual deletion.
Taking this into account, the algorithm calculates the
mean ratio value for each window and assigns it only to
the center of the respective window (Supplementary
Figure 1b, blue dots).
As a consequence, CNVs do not appear with a sharp
transition border at the location of breakpoints but as a
more or less steep slope. For example, Supplementary
Figure 1c shows the ratio proﬁles of the non-ampliﬁed
DNA (upper panel) in comparison with the averaged
ratio proﬁle of the 10-cell pool (lower panel) obtained
with DNA of proband P2. The 10-cell pool ratio was
generated with a window size of 5.000 oligos (corre-
sponding to 325kb). Iterative calculations were made
with windows of the same size, each moved by 1000
oligos. Note that the three largest CNVs (i.e. deletions
with sizes of 3 and 1.2 Mb, and duplication of 532kb)
have already been correctly identiﬁed and are therefore
shown in green and red, respectively. However, the ratio
proﬁle of the 10-cell pool shows no sharp change of the
ratio values at the breakpoints.
Window size and threshold selection. The mean ratio value
is calculated for each window based on the ratio values
it contains. Assuming that a window’s ratio values are
distributed normally, we estimate the SD by considering
the outmost value that is within 34.1% of the mean.
In our previous single cell experiments performed on
BAC-arrays, we deﬁned thresholds as 1.5 times the SD
(9). Due to the higher noise on oligo-arrays as compared
to BAC-arrays, thresholds had to be deﬁned more strin-
gently as 2 times the SD.
Importantly, when testing calculations with various
window sizes we noted that diﬀerent regions may be
called over- or underrepresented. Supplementary
Figure 2a and b illustrate again two calculations of the
10-cell pool of proband P2. Both calculations were made
with ﬁxed window sizes of 500 oligos (corresponding to
32.5kb) (Supplementary Figure 2a) and 2.500 oligos
(162.5kb) (Supplementary Figure 2b). In each case, the
mean ratio for the entire window and not only the
center position is shown. When using the 500 oligo size
windows, many of the respective mean ratio values at the
chromosomal locations of the three largest CNV regions
are above or below the thresholds and are therefore dis-
played in green and red. However, within these regions
there are also many windows which are neither signiﬁ-
cantly increased nor decreased (black colored regions),
and are therefore impeding the distinct identiﬁcation of
CNVs. On the other hand, there are no false positive
calls. When using larger windows, e.g. 2.500 oligos, there
are more regions within the three largest CNVs which are
signiﬁcantly increased or decreased (Supplementary
Figure 2b). However, also some false positive regions
are now identiﬁed which were not observed with the 500
oligo windows.
These data suggest that a simple increase of the window
size alone may not be eﬃcient for improvements of CNV
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ferent window sizes identify diﬀerent regions as over- or
underrepresented suggests that real CNVs should show
speciﬁc patterns if the calculations are repeated with var-
ious window sizes. Furthermore, these patterns should
enable to distinguish between false positive calls and real
existing CNVs as illustrated in Supplementary Figure 2c.
Panel (1) shows four diﬀerent calculations, each with a
diﬀerent window size and threshold, as a diﬀerent SD
exists for every calculation. If a window shows a signiﬁ-
cantly increased or decreased mean ratio value, the mean
position of that window will be displayed above or below
the respective region of the ratio proﬁle [panel (2)].
Depending on the window size it will be labeled with a
diﬀerent color and distance to the X-axis. The thus gener-
ated color bar code facilitates the estimation of the size
of a CNV because the smaller the CNV the less color
bars will be generated [panel (3); compare for example
Figure 2a and b]. For more detailed size estimations the
algorithm generates a table with all localizations of signif-
icant calls which allows the estimation of the CNV size
very accurately.
A correctly identiﬁed CNV should show the smallest
sized windows and also larger windows (depending on
the size of the CNV) which have been determined as sig-
niﬁcant gains or losses [panel (2)]. Other bar code patterns
should not occur as they suggest that regions identiﬁed as
decreased or increased are more likely to be artifacts
[panel (4)]: an example of this would be that no gains
and losses are identiﬁed using the smallest windows but
noted at larger window sizes [panel (4), left; for further
examples see Supplementary Figures 6c and 7]. Due to the
noisy CGH-pattern our algorithm does not require all
windows to be detected as CNVs; although the majority
of windows of a given size should be identiﬁed as gained
or lost. Windows detected as CNVs should be continuous,
thus no gap between the identiﬁcation of two diﬀerent
window sizes should occur [panel (4), center]. A single
call at any window size, except the smallest window size,
is certainly an artifact [panel (4), right]. Therefore the pat-
tern of identiﬁed regions with signiﬁcant deviations from
the mean ratio value can help to distinguish between true
and false positives. This iterative color bar code genera-
tion avoids that a user has to adjust the window size for
an individual experiment, therefore preventing the intro-
duction of user bias.
The only user-deﬁned option to interfere with the data
representation is the selection which of the ratio proﬁles
should be shown in the center.
RESULTS
Cells from clinical cases (probands P1 and P2) and
establishment of their CNV status
We used cells from two probands (P1 and P2). Previous
analyses performed on the whole genome 44K Agilent
array had shown deletions on chromosome 22 with sizes
of 2.8 Mb (P1) and 3 Mb and 1.2 Mb (both P2), respec-
tively. When hybridizing non-ampliﬁed DNA to the
NimbleGen Chromosome 22 Tiling array, we observed
additional CNVs below the resolution limits of the 44K
Agilent array. Proband P1 had an additional duplication
of 272kb (Figure 1a), whereas in proband P2 one
additional deletion (size: 2.5kb) and ﬁve duplications of
various sizes (532, 335, 296, 255 and 85kb) (Figure 1b)
were observed. These additional CNVs, which had been
unknown to us when we designed the experiments, turned
out to be very useful for the estimation of resolution
limits.
For each proband, we prepared cell pools, each consist-
ing of 5 and 10 cells. In addition, we prepared one single
cell from P2 and three diﬀerent single cells from P1. Cell
isolation by laser microdissection and subsequent hybrid-
ization were performed as previously (14). All experiments
were conducted on the NimbleGen Chromosome 22 Tiling
array (HG18 CHR22 FT), all ampliﬁcation products of
proband P2 were hybridized to the Agilent custom-made
chromosome 22 array and the samples of proband P1 were
additionally hybridized to the Whole Genome Tiling
Array (HG18 WG Tiling 2.1M CGH v2.0D).
Evaluation of CNVs of probands P1 and P2 in noisy
ratios in whole genome amplification products
As expected from our previous experience (9), ampliﬁca-
tion products yielded signiﬁcantly noisier ratio proﬁles on
the oligo-arrays than non-ampliﬁed DNA did. SDs are a
reliable estimate of this noise (9). On the NimbleGen
arrays the SDs of non-ampliﬁed DNA were in the range
of about 0.3, whereas for ampliﬁed single-cell or cell-pool
material they increased to values ranging from 0.45 to 0.7
(Table 1). By contrast, the SDs on the Agilent arrays were
generally lower, i.e. about 0.1 for non-ampliﬁed DNA
and 0.35–0.66 for ampliﬁcation products (Table 1).
When trying to evaluate these noisy ratios with currently
used CGH-programs, such as those available on CGHweb
(http://compbio.med.harvard.edu/CGHweb; e.g. CBS,
CGHseg, cghFLasso), CNVs were not detected and/or
the rate of false positive calls was high (data not shown).
This reﬂects that present CGH programs are not designed
for the evaluation of noisy ratio proﬁles.
We therefore developed a new CGH evaluation algo-
rithm. New features of this algorithm include that the
entire evaluation is conducted in an automated way with-
out user interaction in order to avoid that selection of
thresholds or sliding window sizes are inﬂuenced by user
bias. The algorithm iteratively calculates values above or
below thresholds for various window sizes, analyses the
data at progressively greater levels of smoothing and
then combines the data. These calculations result in a pat-
tern distribution of regions identiﬁed as imbalanced,
which allows to distinguish between artifacts and real
imbalances and also to estimate the size of CNVs (details
in ‘Materials and Methods’ section).
In a ﬁrst step, we reevaluated the array-CGH proﬁles of
the non-ampliﬁed DNA, shown in Figure 1, with this
algorithm. As expected, all previously observed gains
and losses could be identiﬁed again (Figure 2a and b).
In addition, we evaluated the DNA of proband P2 on
the custom-made Agilent Chromosome 22 Tiling array
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ratio proﬁle as on the NimbleGen array.
Results obtained with cell samples from proband P2
Analyses of amplification products obtained with 5- and
10-cell pools. The NimbleGen Chromosome 22 Tiling
array comprises 385.210 oligonucleotides and has a
median probe spacing of 65bp. On this array platform,
we detected the three largest CNVs of 3, 1.2 Mb and
532kb with ease (Figure 3a and b) with both ampliﬁcation
products of the cell pools (5 or 10 cells). However, smaller
CNVs could not be identiﬁed.
The custom-made Agilent array consists of 241.700
oligo probes with a median probe spacing of 104bp.
When applying the 5- and 10-cell pools to this array plat-
form, we identiﬁed only the 3 Mb deletion in each case,
but no other CNVs (Supplementary Figures 4a and b).
These results suggest that probe density on the array
platform may have an important impact on resolution
limits. Thus, depending on the array platform resolution
limits for the CNV, detection in cell pools consisting of
5–10 cells are in the range of about 500kb.
Analyses of amplification products obtained with a single
cell. As expected, noise of the single cell ampliﬁcation
Figure 1. Ratio proﬁles of non-ampliﬁed DNA of probands P1 (a) and P2 (b) on the NimbleGen Chromosome 22 Tiling array. The calculation of
these ratio proﬁles was based on a classical approach, using a window size of 100 adjacent oligos (corresponding to 6.5kb) thresholds were simply
determined as 2 times SD. On the NimbleGen arrays losses are illustrated in green above the X-axis, whereas gains are shown in red below the
X-axis. The sizes of observed CNVs are displayed at the respective locations.
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(Table 1), and resulted in a poorer resolution. On the
NimbleGen Chromosome 22 Tiling array, we clearly
detected the 3 Mb-deletion, whereas smaller CNVs could
not be identiﬁed (Figure 4). Similarly, this deletion was
also detected on the Agilent Chromosome 22 Tiling
array (Supplementary Figure 5).
These results suggest that CNVs in single cells with a
size of 3 Mb can be detected on appropriate array
platforms.
Results obtained with cell samples from proband P1
Analyses of amplification products obtained with 5- and
10-cell pools. In general, the hybridization patterns with
the cell samples from proband P1 appeared to be noisier
on the NimbleGen Chromosome 22 Tiling array as com-
pared to proband P2. This is not reﬂected in the SDs
(Table 1), which may be due to the fact that the SDs of
proband P2 are increased as a result of the unexpected
large number of CNVs on chromosome 22. When apply-
ing our evaluation algorithm, this increased noise is
reﬂected in the multiple regions above the threshold,
which could only be identiﬁed with small window sizes
(Figure 5). In both cell pools (5 or 10 cells), we detected
the deletion of 2.8 Mb, but not the duplication of 271kb
(Figure 5a and b). However, the 10-cell pool also identiﬁed
a 650kb large deletion at position 21 Mb (Figure 5a). As
shown below, when the same ampliﬁcation product was
hybridized to another array platform, i.e. the NimbleGen
Whole Genome Array, this deletion was not visible sug-
gesting that this copy number change is a false positive
result and was probably caused by a hybridization artifact
rather than by an ampliﬁcation artifact.
For proband P1, we could also compare the ratio pro-
ﬁles of the NimbleGen Chromosome 22 Tiling array with
the NimbleGen Whole Genome Tiling Array. On the
latter array, chromosome 22 is represented with 26.718
clones, corresponding to median probe spacing of
937bp. We ﬁrst compared the ratio proﬁles obtained
with non-ampliﬁed DNA on both array platforms and
found that these were nearly identical (Supplementary
Figure 6a). With the ampliﬁcation products of the 5-
and 10-cell pools, we again detected the 2.8 Mb deletion
in each case (Supplementary Figure 6b and c).
In this case, there were no signiﬁcant resolution diﬀer-
ences between the two array-platforms. In fact, the
hybridization patterns on the whole genome tiling array
appeared to be less noisy as compared to the chromosome
22 tiling array (compare Figure 5a and b with
Supplementary Figure 6b and c). In summary, our results
suggest that resolution limits for the CNV detection in cell
pools consisting of 5–10 cells are in the range of 500kb.
Analyses of amplification products obtained with single
cells. We hybridized three diﬀerent single cell ampliﬁca-
tion products from proband P1 to the NimbleGen
Chromosome 22 Tiling array. However, only in one of
the three single cells (‘Single cell #1’) of proband P1, we
were able to identify the 2.8 Mb deletion (Figure 6).
When repeating the single cell analyses of cells on
NimbleGen’s Whole Genome Tiling Array, we made the
same observation, i.e. we discovered the 2.8 Mb-deletion
only with the same ampliﬁcation product from the cell
which had allowed us to identify the deletion on the chro-
mosome 22 tiling array (Supplementary Figure 7).
In order to get a more detailed insight whether CNVs
with the size of 2.8–3.0 Mb are only borderline-detectable,
we also evaluated well-known landmarks on the X-chro-
mosome for hybridizations performed on the NimbleGen
2.1M Whole Genome Tiling Array. The X-chromosome is
represented by 106.458 oligos on this array. Proband P1 is
male and the hybridization was carried out with female
reference DNA. Due to the diﬀerent sexes of proband
and reference DNA certain landmarks regions on the
X-chromosome should show a balanced proﬁle, whereas
other regions should show decreased ratio values. The
balanced regions include the ﬁrst pseudoautosomal
region (PAR1; size: 2.6 Mb) at chromosome Xp22.3, the
XY homology region (XY-HR; size: 4 Mb) at chromo-
some Xq21.3, and the second pseudoautosomal region
(PAR2; size: 320kb) at chromosome Xq28
(Supplementary Figure 8a). This expected hybridization
pattern was indeed observed with non-ampliﬁed DNA
(Figure 7a). Moreover, both the PAR1 and XY-HR
were reliably detected in the cell pool hybridizations
(Figure 7b and c) and even in all three single cells
(Figure7d and Supplementary Figure 8b and c).
Analysis of single cells from two cancer cell lines. In order
to further examine how reliably our new algorithm works,
we tested single cells from two cancer cell lines on a 244K
whole-genome array (Agilent). The ﬁrst cell line was the
female renal cell carcinoma cell line 769P. This cell line is
chromosomally very stable as shown by our own previous
analyses (9) and by other extensive studies employing
M-FISH and array-CGH (17,18). Therefore, we expected
that all analyzed cells should show an almost identical
CGH-proﬁle. The second cell line was colorectal cancer
cell line HT29, which has a good level of chromosomal
instability (CIN) with a highly reproducible modal chro-
mosome number (13). Therefore, in this case, we estimated
Table 1. Summary of the standard deviations determined for each
experiment on the various array-platforms
Proband Sample NimbleGen Agilent
Chromosome
22 array
Whole genome
array
Chromosome
22 array
P1 Non-ampliﬁed
DNA
0.29 0.29 ND
Pool 10 cells 0.45 0.50 ND
Pool 5 cells 0.42 0.68 ND
Single cell #1 0.59 0.75 ND
Single cell #2 0.80 0.89 ND
Single cell #3 0.66 1.05 ND
P2 Non-ampliﬁed
DNA
0.30 ND 0.11
Pool 10 cells 0.51 ND 0.30
Pool 5 cells 0.59 ND 0.35
Single cell #1 0.87 ND 0.66
ND: Not done.
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Thus, in addition to testing our algorithm’s robustness,
we could also address the phenomenon of CIN, which is
frequently observed in cancer and which is characterized
by cell-to-cell variability (19).
In cell line 796P areas of copy number change identiﬁed
by hybridization of non-ampliﬁed DNA could also be
detected with the single cell products. To test the reprodu-
cibility of the algorithm we compared the ratio proﬁle of
non-ampliﬁed DNA (Supplementary Figure 9a) with four
single cells which met our described quality criteria. For
example, chromosome 1 harbors the equivalent of a single
copy deletion on the p-arm covering a region of 30 Mb
and the equivalent of a single copy gain on the q-arm of
90 Mb (9). 769P also has a small single copy deletion on
chromosome 9 of 6.3 Mb (genomic position 16.7–23.0
Mb) (9). These regions of copy number change were
easily identiﬁed in single-cell ampliﬁed material and non-
ampliﬁed DNA (Supplementary Figure 9b). We indeed
always discovered the same numerical aberrations and,
notably, the 6.3 Mb deletion on chromosome 9p was
detected in each cell.
Cellline HT29 isneartriploid and,according toprevious
publications, shows relative excess of chromosome arms
Figure 2. This ﬁgure displays the same ratio proﬁles as in Figure 1a and b, i.e. the ratio proﬁles of probands P1 (a) and P2 (b), now calculated with
the algorithm described in this manuscript. The center proﬁle is based on calculations with window sizes of 100 adjacent oligos (corresponding to
6.5kb). A color bar code presents the window size (each in adjacent oligos and the respective physical size) for which calculations have been
conducted. In the case of non-ampliﬁed DNA we selected very small window sizes, in the other cases with whole genome ampliﬁcation products the
window sizes were larger.
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18q and 21q, and pronounced intermetaphase variation
(13). To the best of our knowledge, no high-resolution
array-CGH proﬁle of this cell line has been published
yet. However, a partial high-resolution proﬁle is available
on the Agilent web-page (http://www.servicexs.com/blobs
/Agilent/Agilent_CGH_brochure.pdf). Our array-CGH
proﬁle obtained with non-ampliﬁed DNA was consistent
with previously published numerical aberrations (13) and
with gains and losses described on the aforementioned
Agilent web-page (Supplementary Figure 10a). This
cell line also harbors two small homozygous deletions on
16p (size: 1.29 Mb; genomic position 6.0–7.3 Mb) and
on 20p (size: 1.81 Mb; genomic position 14.2–16.0 Mb).
Figure 3. Cell-pool results obtained for proband P2 on the NimbleGen Chromosome 22 Tiling array. (a) Evaluation of the 10-cell pool on the
NimbleGen Chromosome 22 Tiling array. The proﬁle shown in the center was obtained with a window size of 5.000 oligos (corresponding to 325kb).
The two largest CNVs show bar codes from black to cyan, demonstrating that the size of the CNVs is in the range of 1.3 Mb or larger (actual sizes: 3
and 1.2 Mb, respectively; compare Figure 1b). In contrast, the largest duplication has a bar code ranging only from black to blue, showing that the
size of this CNV is somewhere between 325 and 650kb (the actual size is 532kb, Figure 1b). To the left side of this duplication another region at
position 26.5 Mb appears to be potentially duplicated. However, the calls are not uninterrupted from black to blue, as there is no pink bar revealing
that this CNV call is likely to be an artifact [compare panel (4) in Supplementary Figure 2c]. (b) Hybridization of the 5-cell pool from proband P2 on
the NimbleGen Chromosome 22 Tiling array resulted in a CNV recognition pattern similar to that of the 10-cell pool. The algorithm shows the
presence of the 255kb large duplication at position of about 44.7–44.8 (compare Figure 1b), however, the larger 296 and 335kb duplications were
not identiﬁed.
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easily observed in all four diﬀerent single cells shown
in Supplementary Figure 10b–e. Interestingly, we could
even unequivocally identify the small deletions on 16p
and 20p in three cells (16p deletion: Supplementary
Figure 10c–e; 20p deletion: Supplementary Figure 10b, d
and e). In the other cells the ratios at the respective regions
were decreased, yet they did not exceed the threshold.
Thus, it may be especially easy to detect very small (<2
Mb) homozygous deletions in single cell ampliﬁcation
products.
As expected from the previously reported intermeta-
phase variation (13), we also observed some alterations
not present in all cells. The best example is the deletion
of the distal part of 6q. This deletion is easily visible with
non-ampliﬁed DNA, however, the decrease of the ratio
values is not as pronounced as e.g. for 3p or the distal
region of 4q (Supplementary Figure 10a), suggesting
that this numerical change may be present as mosaic. In
fact, in two (Supplementary Figure 10c and d) of the four
analyzed single cells, we observed a balanced ratio proﬁle
for the entire chromosome 6. In one cell (Supplementary
Figure 10b) there was no gain of 18p, which was other-
wise visible in all other cells and also in cells from
non-ampliﬁed DNA. Furthermore, in another cell we
observed a large, balanced region within an area on chro-
mosome 7, which was overrepresented in all other cells
(Supplementary Figure 10c). This suggests that CIN is in
this cell line not only caused by whole-chromosome
changes but also by structural rearrangements result-
ing in segmental aneuploidies. Applying single-cell
array-CGH, we had previously made similar observations
with the colorectal cell line HCT116 (9).
Analysis of polar bodies
Polar bodies represent an interesting model as chromo-
somal gains and losses observed in the ﬁrst and second
polar body should complement one another to a large
extent. For example, a gain of a certain chromosome in
the ﬁrst polar body leaves two options for this chromo-
some for the second polar body: ﬁrst the same chromo-
some could be lost, indicating a balanced status for this
chromosome in the oocyte, or it could be balanced, indi-
cating a loss of this chromosome in the oocyte. However,
the gain of a certain chromosome should never be
observed in both the ﬁrst and the second polar body and
the same applies for the loss of a chromosome. In preim-
plantation genetic diagnosis, we focus on polar bodies as
Austrian legislation prohibits the analyses of blastomeres.
By now, we have analyzed by CGH 231 polar bodies,
including 170 matching ﬁrst and polar bodies demonstrat-
ing that our approach is highly reliable even for the anal-
yses of haploid genomes (manuscript in preparation).
Here we present an particularly interesting pair of ﬁrst
and second polar bodies showing complementary gains
and losses for chromosomes 1, 9, 10, 13, 18, 20 and 21
(Supplementary Figure 11a and b). However, the ﬁrst
polar body had in addition a gain of chromosome 14
(Supplementary Figure 11a), whereas the second polar
body had additional gains of chromosomes 16 and17
and losses of chromosomes 2, 3, 4, 6, 7, 11 and 15
(Supplementary Figure 11b). Thus, the corresponding
oocyte should be unbalanced.
Inspection of the ratio proﬁles revealed another inter-
esting phenomenon: in each polar body ratio, values were
at four diﬀerent levels. For example, in the ﬁrst polar body
(Supplementary Figure 11a), we observed chromosomes
Figure 4. Chromosome 22 proﬁle for proband P2 obtained with a single cell ampliﬁcation product on the NimbleGen Chromosome 22 Tiling
array. Beside the 3 Mb deletion, the bar code pattern displays a possible presence of two smaller deletions at positions 34 and 38 Mb with sizes
between 650kb and 1.3 Mb. The deletion at position 38 Mb corresponds to the location of the real existing 1.2 Mb deletion. However, the second
putative deletion at position 34 Mb is false positive, demonstrating that CNVs with a size of <2 Mb cannot be reliably detected in a single cell. Here
the center proﬁle was obtained with a 20.000 oligo sliding window (1.3 Mb).
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10, 14 and 19), 0 (i.e. chromosomes 2, 3, 4, 6, 7, 11, 15, 22),
0.3 (i.e. chromosomes 5, 8, 12, 16, 17), and 1.5 (i.e.
chromosomes 1, 9, 13, 18, 20, 21). These diﬀerent ratio
levels are indicated on the right side of each ﬁgure (‘1–4’;
Supplementary Figure 11). If the two meiotic divisions
proceed without any errors, the ﬁrst polar body should
receive 23 chromosomes, each consisting of two chroma-
tids, whereas the second polar body should get 23
chromosomes, each consisting of one chromatid. The
four diﬀerent levels of ratio values we observed in this
and other (manuscript in preparation) polar body pairs
most likely reﬂects that meiotic segregation errors even
during meiosis I may involve not only chromosomes but
also single chromatids. This pair of polar bodies and
results from other polar bodies (our unpublished data)
demonstrate that high rates of chromosome segregation
errors may occur during female meiosis.
Figure 5. Cell-pool results obtained for proband P1 on the NimbleGen Chromosome 22 Tiling array. (a) Hybridization of the 10-cell pool
clearly identiﬁed the 2.8Mb-deletion. The algorithm also identiﬁed another deletion with a size of about 650kb at position 21Mb. This deletion
is likely to be an artifact (compare Supplementary Figure 6b and details in text). (b) The 5-cell pool of proband P1 also allowed precise
identiﬁcation of the 2.8 Mb-deletion. In addition, at positions 27 and 32 Mb, the algorithm shows the possible presence of two further deletions,
each with a size below the 500kb limit for reliable CNV identiﬁcation in cell pools. At position 23–24 Mb some bar codes reveal a duplication,
which in fact corresponds to the real 272kb duplication. In both cases the center proﬁle was obtained with a sliding window of 5.000 oligos
(325kb).
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In this study, we evaluated the performance of ampliﬁca-
tion products from cell pools or single cells on oligo tiling
path arrays. Our results suggest that the use of arrays with
a suﬃcient density of oligos allows the reliable detection of
CNVs with a size of 3 Mb (P2) or 4 Mb (size of XY-HR).
However, below 3 Mb, the detection of CNVs in single
cells becomes critical as we missed a deletion of 2.8 Mb in
2 of 3 cells, whereas we identiﬁed the PAR1 region of 2.6
Mb on the X-chromosome in all of these three analyzed
single cells. This indicates that reliable detection of CNVs
with a size range of below 3 Mb is already at the resolution
limit of present protocols for single cell analysis. In con-
trast, both robustness and resolution increase if only 5 or
10 cells are being analyzed, as we were able to identify
CNVs as small as 500kb in such cell pools.
Conﬁrming our previous observations (9) our results
again demonstrate that CGH-proﬁles from single cells or
from a few cells are signiﬁcantly noisier than those from
non-ampliﬁed DNA. Ampliﬁcation of the entire genome
of a single cell most likely includes multiple stochastic
ampliﬁcation events due to the low amount of template
DNA. Thus, while whole genome ampliﬁcation products
appear to be ‘unbiased’ at low resolution, e.g. if hybridized
to metaphase chromosomes [as shown for example by (12)
or (20)], variant ampliﬁcation becomes more obvious on
oligo tiling arrays and aﬀects the detection sensitivity of
small CNVs.
This requires particularly sensitive methods for data
interpretation. Currently available array-CGH programs
have been developed for the evaluation of ratio proﬁles
with limited noise, which are usually achieved when non-
ampliﬁed DNA is used.
In previous experiments when we (9) or others
(8,10) tested the performance of ampliﬁed DNA on
array-platforms, the standard procedure involved a com-
parison of ratio proﬁles obtained with ampliﬁed DNA
versus a baseline proﬁle usually generated with non-ampli-
ﬁed DNA. Resolution is then estimated based on the con-
cordance between the two ratio proﬁles. During these
comparisons users will presumably adjust parameters,
such as window smoothing or thresholds, until the best
correlation between the proﬁles is achieved. However,
since whole genome ampliﬁcation of single cells or few
cells involves a number of stochastic events, CGH-evalua-
tion parameters, which may be optimal for a particular
single cell experiment, may be less suited in the next
experiment. Accordingly, lacking the option of a compar-
ison with a baseline-ratio proﬁle, the user will not know
which parameters are optimal for a most sensitive CNV
identiﬁcation. In fact, in most scenarios performing single
cell/few cell analyses reliable baseline proﬁles are not
available for comparison, because otherwise there would
be no need for an elaborate single cell analysis.
Accordingly, our tests with various standard array-CGH
programs revealed in fact that these had not been devel-
oped for noisy CGH-patterns and therefore they are not
suited for the identiﬁcation of very small changes in extre-
mely noisy CGH ratio patterns.
For these reasons we developed a new algorithm with
the speciﬁc aim of detecting small CNVs in very noisy
ratio proﬁles. For the aforementioned reasons the algo-
rithm excludes user interaction. Instead, ratios are itera-
tively calculated at progressively greater levels of
smoothing and the analyses are then combined. This gen-
erates a pattern of regions gained or lost. Based on such a
pattern the algorithm determines regions of signiﬁcant
ratio deviation. Thus, the main advantages over and dif-
ferences from other CGH-programs include (i) no user
interaction and thus avoidance of user bias; (ii) identiﬁca-
tion of small CNVs in noisy ratio proﬁles; (iii) distinction
Figure 6. Identiﬁcation of the 2.8 Mb deletion in a single cell (‘#1’) of proband P1 on the NimbleGen Chromosome 22 Tiling array. The center
proﬁle was generated using a 20.000 oligo sliding window (1.3 Mb).
PAGE 11 OF 13 Nucleic Acids Research, 2009,Vol.37, No. 15 e105Figure 7. Ratio proﬁles of the X-chromosome. (a) Evaluation of the X-chromosome with non-ampliﬁed DNA. All X-chromosome landmark
regions, i.e. PAR1, PAR2 and the XY-homology region (compare Supplementary Figure 8a) are identiﬁed. (b) X-chromosome evaluation of the
10-cell pool, which results in a similar ratio proﬁle as obtained with the non-ampliﬁed DNA. (c) X-chromosome evaluation of the 5-cell pool, again
with a similar ratio proﬁle. (d) X-chromosome evaluation of the single cell ‘#1’ from proband P1. For this cell the deletion on chromosome 22
was also identiﬁed.
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estimates for CNVs based on color coding and tables
listing positions of over- and underrepresented regions.
Our comparisons of the ratio proﬁles between diﬀerent
chromosome 22 tiling array platforms and other oligo
tiling arrays suggest that probe density on the array may
have an important impact on the resolution limits.
Furthermore, as demonstrated in our cell pool experi-
ments, stochastic ampliﬁcation artifacts are already
reduced if only 5 or 10 cells are ampliﬁed, resulting in a
drastic improvement of both robustness and resolution.
This will pave the way for the establishment of detailed
CNV-maps from small cell numbers. In addition, we
demonstrated that speciﬁc biological questions can now
be addressed with unprecedented resolution such as CIN
in biological samples including cancer cells or polar bodies.
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